WHAT ’ S IN A WHAT’S IN A vial NUCEIVA is designed with precision to put control in the hands of the provider. Pr TM
EVOLVE WITH US.
100u vial
900 kDa
2.5
mL
diluent
PROGRESSION OF RESULTS
VIAL 100 units of botulinum toxin type A neurotoxin complex, 0.5 mg human serum albumin (HSA), and 0.9 mg sodium chloride (NaCl). Sterile, vacuum dried without a preservative and stored at 2-8 °C
RECONSTITUTION Reconstitute the 100 unit vial with 2.5 mL preservative-free 0.9% sodium chloride injection (not included) to obtain a concentration of 4 units/0.1 mL
MOLECULAR MASS Botulinum toxin type A that is purified from clostridium botulinum
DAY
DAY 2 30 120 DAY
DAY
0
SERIOUS WARNINGS AND PRECAUTIONS DISTANT SPREAD OF TOXIN EFFECT: The effects of NUCEIVA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life-threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms. INDICATIONS AND USAGE: NUCEIVA™ is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients < 65 years of age. Pr Manufactured by: Evolus, Inc., 520 Newport Center Drive, Suite 1200, Newport Beach, CA 92660 ©2024 Evolus Inc. All rights reserved. NUCEIVA is a trademark of Evolus, Inc.
prabotulinumtoxinA for injection
26
Made with FlippingBook interactive PDF creator